Renalytix RNLXY
OTC RNLXY
$3.70 -0.09 (-2.37%)
At close: Nov 6, 2026 · 4:00 PM EST

Renalytix (RNLXY) Common Equity (2018 - 2024)

Updated

Renalytix (RNLXY) posted Common Equity of -$11.32 million for fiscal Q1 2025 (quarter ended Sep 30, 2024), compared with -$1.49 million a year earlier.

Analysis

Renalytix (RNLXY) Common Equity (2018 - 2024) Analysis & Trends

At the end of FY2024 (ended Jun 30, 2024), Renalytix's Common Equity came in at -$7.85 million.

  • In prior fiscal years, Renalytix's Common Equity was $6.97 million in FY2023 (-77.2%), $30.61 million in FY2022 (-57.2%), $71.46 million in FY2021 (+349.1%) and $15.91 million in FY2020 (+86.1%).
  • The fiscal Q1 2025 figure stands as the lowest quarterly Common Equity in data going back to fiscal Q4 2018.
  • The strongest year-over-year quarter for Common Equity in the past five years was fiscal Q4 2021, with growth of 349.1%; the weakest was fiscal Q2 2023, with a decline of 80.6%.
  • According to Business Quant data, Common Equity for the three prior fiscal quarters was -$7.85 million (Q4 2024), -$11.11 million (Q3 2024) and -$7.96 million (Q2 2024).
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2024 -11.32 Mn
Jun 30, 2024 -7.85 Mn
Mar 31, 2024 -11.11 Mn
Dec 31, 2023 -7.96 Mn
Sep 30, 2023 -1.49 Mn
Jun 30, 2023 6.97 Mn
Mar 31, 2023 18.10 Mn
Dec 31, 2022 8.89 Mn
Sep 30, 2022 18.84 Mn
Jun 30, 2022 30.61 Mn
Mar 31, 2022 29.42 Mn
Dec 31, 2021 45.80 Mn
Sep 30, 2021 59.97 Mn
Jun 30, 2021 71.46 Mn
Mar 31, 2021 80.03 Mn
Dec 31, 2020 86.90 Mn
Jun 30, 2020 15.91 Mn
Jun 30, 2019 8.55 Mn
Jun 30, 2018 -502,000.00
API Access

Renalytix Common Equity API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=common-equity&ticker=RNLXY&period=max&api_key=YOUR_API_KEY